Hereditary spherocytosis is an intrinsic metabolic disorder of erthrocytes characterized by the presence of microcytes and spherocytes in the peripheral blood. It is believed to be due to a derangement in the energy-yielding reactions of glycolysis within the membrane of the erythrocyte. It has been calculated to occur once in every 20,000 births. Though it is not racially restricted, it has been reported most frequently in persons of northern European origin (Harris, 1963) .
Beta thalassaemia is a hereditary disturbance in the mechanism of synthesis of the beta polypeptide chain characteristic of the major adult haemoglobin molecular species. It occurs more frequently than spherocytosis, particularly in countries around the Mediterranean littoral and in the Near and the Far East. There are various forms of beta thalassaemia and nearly all of them are characterized by an increase in the Hb A2 fraction to approximately double the normal level.
One form of beta thalassaemia was described almost simultaneously in Italy by Silvestroni and Bianco (1957) and by Carcassi, Ceppellini, and Siniscalco (1957) , in which the increased Hb A2 concentration was not associated with the usual abnormal morphological characteristics of the erythrocytes, and which appeared to be transmitted as a Mendelian dominant character. Similar findings have been reported in Greek subjects (Gouttas 1962) and in a British family (Callender, Mallett, and Lehmann, 1961) . This variant has been reported in three genetic forms: heterozygous, presumed homozygous, and in combination with classical beta thalassaemia (Silvestroni and Bianco, 1966; Quattrin, Dini, and Ventruto, 1964) . It has been variously described as: 'elevated A2 haemoReceived November 8, 1966. globin without morphologic thalassaemia' (Bannerman, 1961) , 'beta chain thalassaemia in absence of a thalassaemia-like picture' (Fessas, 1965) , 'isolated increase of haemoglobin A2' (Silvestroni and Bianco, 1966) , and 'elevated Hb A2 without microcythaemia' (Quattrin et al., 1964 (Cohen, Zuelzer, Neel, and Robinson, 1959) . In this patient the thalassaemia variant which was postulated produced the characteristic erythrocyte morphology but not the increase in Hb A2. This gave rise to the concept of a 'non-interacting' form of thalassaemia. The suggestion was also made that the expression of this thalassaemia gene was masked by the presence of the gene for spherocytosis.
We would like to record the finding of spherocytosis and a raised Hb A2 level, in the absence of the 109 morphological characteristics of thalassaemia, in a white subject. This is the first description of this combination of hereditary intra-erythrocytic de- (2) The absence of any morphological characteristics of the erythrocytes attributable to thalassaemia in the patient's brother: this suggests that the morphological abnormalities (microcytosis, mild anisocytosis, and mild polychromasia) in the patient's erythrocytes were due to the spherocytosis component.
(3) The lack of any clinical or laboratory evidence of interaction between the two intra-erythrocytic defects or of accentuation of the pathogenicity of either.
(4) The prolonged clotting time.
There are reports of the combination of hereditary spherocytosis with a number of other hereditary anomalies of the erythrocyte. Thus, the combination of spherocytosis and sickling is well known (Cohen et al., 1959; Smith and Conley, 1954; De Torregrosa, Ortiz, and Vargas, 1956; Jones and Klingberg, 1959; Martin, Kough, and Branche, 1959; Whitaker, Windmiller, Vietti, and Sartain, 1963) . The simultaneous presence of three erythrocytic defects (spherocytosis, haemoglobin C, and sickling) has been found in one family (Thompson and Robertson, 1964) , while the combination of spherocytosis, sickling, and an unusual variety of thalassaemia was presumed present in a Negro woman (Cohen et al., 1959 There is no evidence that the simultaneous presence of the genes for spherocytosis and the beta thalassaemia variant in our patient in any way interfered with the expression or clinical manifestation of either. A similar lack of interaction can be inferred from study of the published reports on patients with the combination of hereditary elliptocytosis and classical beta thalassaemia (Brumpt, Delabarre, and De Traverse, 1960; De Vries, De Jong, and Frenkel, 1959; Aksoy, 1963; Perillie and Chernoff, 1965) . Absence of the haematological stigmata of a postulated thalassaemia gene in the presence of spherocytosis was noted by Cohen et al. (1959) in their patient. This they attributed to a suppression or masking of the thalassaemia effect, by the spherocytosis gene. However, the thalassaemia gene they postulated did not produce an increase in haemoglobin A2 level. In our patient this explanation is not tenable since his brother also had a raised haemoglobin A2 level in the absence of any noticeable morphological abnormalities. The thalassaemia gene in our family, therefore, is of the kind that is expressed as an isolated raised haemoglobin A2 level.
No explanation can be offered for the finding of a prolonged clotting time and incomplete clot retraction in our patient. There was no history of a haemorrhagic diathesis in the patient or his family. The situation is different, therefore, from that reported by Chatterjea (1956) in a Hindu family in which both spherocytosis and 'pseudo haemophilia' were present and occurred together in one member.
Summary
A case report is presented of a male Jordanian of Syrian origin in whom the combination of spherocytosis and a beta thalassaemia variant (isolated raised haemoglobin A2 level) occurred. This is the first description of this combination of hereditary intrinsic abnormalities of the erythrocyte. There was no evidence of interaction between the two genes. The genetic combination was asymptomatic and was discovered during routine pre-operative investigation. This work is supported by a grant from the Medical Research Council of Canada to F. V.
